ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,019, issued on Sept. 22, was assigned to Wisconsin Alumni Research Foundation (Madison, Wis.).
"Antibodies targeting glioblastoma stem-like cells and methods of use thereof" was invented by Michael Zorniak (San Diego), Paul A. Clark (Madison, Wis.), Yongku Peter Cho (Storrs, Conn.), Benjamin J. Umlauf (Madison, Wis.), Eric V. Shusta (Madison, Wis.) and John Shu-Shin Kuo (Austin, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides antibodies that target glioblastoma stem-like cells and methods and kits for their use."
The patent was filed on Sept. 7, 2023, under Application No. 18/463,154.
*For further information, ...